Reliv International Inc (RELV) 2.06 $RELV
Reliv International Reports First-Quarter Financial Results for 2014
GlobeNewswire - Wed Apr 30, 6:16AM CDT
Reliv International, Inc. (Nasdaq:RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results for the first quarter of 2014.
Reliv Introduces New LunaRich Super Packs
PRWeb - Mon Mar 31, 1:07PM CDT
Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today announced the launch of the LunaRich(R) Super Pack, a product package designed to facilitate new customer purchases and new distributor sign-ups. The launch took place through an online event on Saturday, March 29.
Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2013
GlobeNewswire - Wed Mar 05, 5:45AM CST
Reliv International, Inc. (Nasdaq:RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results for the fourth quarter and full year of 2013.
Reliv Strengthens LunaRich Ingredient Patent
PRWeb - Fri Feb 28, 5:24AM CST
Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today announced that the US Patent and Trademark Office has issued an expanded composition of matter patent for LunaRich(R) technology. LunaRich is a Reliv-exclusive nutritional ingredient. The updated patent further protects LunaRich technology as it relates to enhancing lunasin bioactivity and its superior ability to deliver bioactive lunasin to the body. Lunasin is a naturally occurring peptide scientists have identified as the key to many of soy's documented health benefits.
Reliv Kalogris Foundation Opens School for Orphans in Haiti
PRWeb - Mon Jan 13, 5:07AM CST
The Reliv Kalogris Foundation (RKF), the charitable arm of Reliv International, Inc., today announced the opening of St. John the Baptist National School of Petite-Anse, Haiti. The school building, damaged in the 2010 earthquake, had been declared unsafe for use in case of future earthquakes. The RKF provided funds to upgrade the building for sanctioned use as a functioning elementary school.
LunaRich, Nutritional Epigenetics Provide Business Boost for Reliv
PRWeb - Wed Nov 27, 5:01AM CST
Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today attributed much of the company's recent sales growth to Reliv bringing the science of nutritional epigenetics to the marketplace. "In the past year we've positioned ourselves as the industry leader in this emerging field," said Ryan Montgomery, Reliv president. "LunaRich(R) is the first epigenetic superfood, and it's giving our consumers a whole new way to think about nutrition and human health."
Study Shows Potential Health Benefits of Lunasin-Based Supplement Program
PRWeb - Thu Sep 19, 5:31AM CDT
Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today released the results of a promising new study. In the University of Missouri study, pigs supplemented daily with Reliv Now(R) and LunaRich X(TM) for eight weeks showed significant improvement in key biomarkers associated with cardiovascular and metabolic health.
Reliv's LunaRich Earns Ingredient Patent
Marketwire - Fri Aug 23, 3:21PM CDT
Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today announced that LunaRich(R) has earned a new patent from the US Patent and Trademark Office. The composition of matter patent protects the LunaRich technology as it relates to its superior ability to deliver bioactive lunasin to the body. Lunasin is a naturally occurring peptide scientists have identified as the key to many of soy's documented health benefits.
i"Reliv International Inc awarded US patent for Healthy Energy Shot 24K, reflecting its ninth in nutritional formula
M2 - Thu Aug 22, 6:39AM CDT
Nutritional supplements company Reliv International Inc (NasdaqGS:RELV) reported on Wednesday the receipt of the patent for its healthy energy shot 24K from the US government.
Healthy Energy Shot 24K Becomes Ninth Reliv Product to Earn Patent
GlobeNewswire - Wed Aug 21, 11:25AM CDT
Reliv International, Inc. (Nasdaq:RELV), a maker of nutritional supplements that promote optimal health, this week announced that healthy energy shot 24K(TM) has earned a patent from the US government. Dr. Carl W. Hastings, Reliv's chief scientific officer and creator of 24K, made the announcement as part of opening night at Reliv's 25th Anniversary International Conference.
Reliv's LunaRich X Wins People's Choice Stevie Award
PRWeb - Wed Aug 21, 5:07AM CDT
Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today announced that LunaRich X(TM) was named winner of the People's Choice Stevie(R) Award for Favorite New Consumer Product in the 11th Annual American Business Awards.
Reliv Kalogris Foundation Dedicates Nutrition Center for Impoverished Children in the Philippines
PRWeb - Mon Aug 12, 5:09AM CDT
The Reliv Kalogris Foundation today announced the completion of their latest building project: a nutrition center for impoverished children in Welfareville, a depressed area in Mandaluyong City, Philippines. The RKF, the charitable arm of Reliv International, Inc. (NASDAQ: RELV), raised funds for the project through last year's annual Rally for the Mission at the 2012 Reliv International Conference.
Reliv International Reports Second-Quarter Financial Results
GlobeNewswire - Thu Aug 01, 5:45AM CDT
Reliv International, Inc. (Nasdaq:RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results for the second quarter of 2013.
Double In Stocks Mid Day Alert
WorldStockWire - Wed Jul 31, 12:30PM CDT
DoubleInStocks.com, a division of Crown Equity Holdings Inc. (OTCQB:CRWE) tracks stocks daily and is pleased to offer its hot stock to watch . Our mid day stock focus today is on:
Reliv Acquires Exclusive Rights to 'Superfood' Lunasin
GlobeNewswire - Wed Jul 24, 10:30AM CDT
Reliv International, Inc. (Nasdaq:RELV), a maker of nutritional supplements that promote optimal health, today announced that it has entered into an exclusive license for the intellectual property of Soy Labs LLC related to the nutritional ingredient lunasin. Lunasin is a naturally occurring peptide research has identified as the key to many of soy's documented health benefits, from cholesterol reduction to general cellular health.
Reliv Conference to Feature Presentation on Lunasin and Nutritional Epigenetics
PRWeb - Fri Jun 28, 6:10AM CDT
Reliv International (NASDAQ: RELV) today announced that the company's 25th anniversary conference in Orlando on July 18-20 will include a presentation on nutritional epigenetics and the science behind the soy peptide lunasin. Presenters will include Dr. Carl Hastings, Reliv chief scientific officer, and Dr. Alfredo Galvez, research scientist at the Center of Excellence in Nutritional Genomics at UC Davis and lead scientific advisor at the Missouri Plant Science Center (MPSC).
Reliv International Reports First-Quarter Financial Results for 2014
GlobeNewswire - Wed Apr 30, 6:16AM CDT
Reliv International, Inc. (Nasdaq:RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results for the first quarter of 2014.
Reliv Introduces New LunaRich Super Packs
PRWeb - Mon Mar 31, 1:07PM CDT
Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today announced the launch of the LunaRich(R) Super Pack, a product package designed to facilitate new customer purchases and new distributor sign-ups. The launch took place through an online event on Saturday, March 29.
Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2013
GlobeNewswire - Wed Mar 05, 5:45AM CST
Reliv International, Inc. (Nasdaq:RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results for the fourth quarter and full year of 2013.
Reliv Strengthens LunaRich Ingredient Patent
PRWeb - Fri Feb 28, 5:24AM CST
Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today announced that the US Patent and Trademark Office has issued an expanded composition of matter patent for LunaRich(R) technology. LunaRich is a Reliv-exclusive nutritional ingredient. The updated patent further protects LunaRich technology as it relates to enhancing lunasin bioactivity and its superior ability to deliver bioactive lunasin to the body. Lunasin is a naturally occurring peptide scientists have identified as the key to many of soy's documented health benefits.
Reliv Kalogris Foundation Opens School for Orphans in Haiti
PRWeb - Mon Jan 13, 5:07AM CST
The Reliv Kalogris Foundation (RKF), the charitable arm of Reliv International, Inc., today announced the opening of St. John the Baptist National School of Petite-Anse, Haiti. The school building, damaged in the 2010 earthquake, had been declared unsafe for use in case of future earthquakes. The RKF provided funds to upgrade the building for sanctioned use as a functioning elementary school.
LunaRich, Nutritional Epigenetics Provide Business Boost for Reliv
PRWeb - Wed Nov 27, 5:01AM CST
Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today attributed much of the company's recent sales growth to Reliv bringing the science of nutritional epigenetics to the marketplace. "In the past year we've positioned ourselves as the industry leader in this emerging field," said Ryan Montgomery, Reliv president. "LunaRich(R) is the first epigenetic superfood, and it's giving our consumers a whole new way to think about nutrition and human health."
Study Shows Potential Health Benefits of Lunasin-Based Supplement Program
PRWeb - Thu Sep 19, 5:31AM CDT
Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today released the results of a promising new study. In the University of Missouri study, pigs supplemented daily with Reliv Now(R) and LunaRich X(TM) for eight weeks showed significant improvement in key biomarkers associated with cardiovascular and metabolic health.
Reliv's LunaRich Earns Ingredient Patent
Marketwire - Fri Aug 23, 3:21PM CDT
Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today announced that LunaRich(R) has earned a new patent from the US Patent and Trademark Office. The composition of matter patent protects the LunaRich technology as it relates to its superior ability to deliver bioactive lunasin to the body. Lunasin is a naturally occurring peptide scientists have identified as the key to many of soy's documented health benefits.
i"Reliv International Inc awarded US patent for Healthy Energy Shot 24K, reflecting its ninth in nutritional formula
M2 - Thu Aug 22, 6:39AM CDT
Nutritional supplements company Reliv International Inc (NasdaqGS:RELV) reported on Wednesday the receipt of the patent for its healthy energy shot 24K from the US government.
Healthy Energy Shot 24K Becomes Ninth Reliv Product to Earn Patent
GlobeNewswire - Wed Aug 21, 11:25AM CDT
Reliv International, Inc. (Nasdaq:RELV), a maker of nutritional supplements that promote optimal health, this week announced that healthy energy shot 24K(TM) has earned a patent from the US government. Dr. Carl W. Hastings, Reliv's chief scientific officer and creator of 24K, made the announcement as part of opening night at Reliv's 25th Anniversary International Conference.
Reliv's LunaRich X Wins People's Choice Stevie Award
PRWeb - Wed Aug 21, 5:07AM CDT
Reliv International, Inc. (NASDAQ: RELV), a maker of nutritional supplements that promote optimal health, today announced that LunaRich X(TM) was named winner of the People's Choice Stevie(R) Award for Favorite New Consumer Product in the 11th Annual American Business Awards.
Reliv Kalogris Foundation Dedicates Nutrition Center for Impoverished Children in the Philippines
PRWeb - Mon Aug 12, 5:09AM CDT
The Reliv Kalogris Foundation today announced the completion of their latest building project: a nutrition center for impoverished children in Welfareville, a depressed area in Mandaluyong City, Philippines. The RKF, the charitable arm of Reliv International, Inc. (NASDAQ: RELV), raised funds for the project through last year's annual Rally for the Mission at the 2012 Reliv International Conference.
Reliv International Reports Second-Quarter Financial Results
GlobeNewswire - Thu Aug 01, 5:45AM CDT
Reliv International, Inc. (Nasdaq:RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results for the second quarter of 2013.
Double In Stocks Mid Day Alert
WorldStockWire - Wed Jul 31, 12:30PM CDT
DoubleInStocks.com, a division of Crown Equity Holdings Inc. (OTCQB:CRWE) tracks stocks daily and is pleased to offer its hot stock to watch . Our mid day stock focus today is on:
Reliv Acquires Exclusive Rights to 'Superfood' Lunasin
GlobeNewswire - Wed Jul 24, 10:30AM CDT
Reliv International, Inc. (Nasdaq:RELV), a maker of nutritional supplements that promote optimal health, today announced that it has entered into an exclusive license for the intellectual property of Soy Labs LLC related to the nutritional ingredient lunasin. Lunasin is a naturally occurring peptide research has identified as the key to many of soy's documented health benefits, from cholesterol reduction to general cellular health.
Reliv Conference to Feature Presentation on Lunasin and Nutritional Epigenetics
PRWeb - Fri Jun 28, 6:10AM CDT
Reliv International (NASDAQ: RELV) today announced that the company's 25th anniversary conference in Orlando on July 18-20 will include a presentation on nutritional epigenetics and the science behind the soy peptide lunasin. Presenters will include Dr. Carl Hastings, Reliv chief scientific officer, and Dr. Alfredo Galvez, research scientist at the Center of Excellence in Nutritional Genomics at UC Davis and lead scientific advisor at the Missouri Plant Science Center (MPSC).
